- Tytuł:
-
Saxagliptin add-on therapy to insulin with or without
metformin for type 2 diabetes mellitus: 52-week safety and efficacy. - Autorzy:
- Źródło:
- Clinical drug investigation [Clin Drug Investig] 2013 Oct; Vol. 33 (10), pp. 707-17.
- Typ publikacji:
- Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
- MeSH Terms:
-
Adamantane/*analogs & derivatives
Diabetes Mellitus, Type 2/*drug therapy
Dipeptides/*administration & dosage
Dipeptidyl-Peptidase IV Inhibitors/*administration & dosage
Hypoglycemic Agents/*administration & dosage
Insulin/*administration & dosageMetformin /*administration & dosage
Adamantane/administration & dosage ; Adamantane/adverse effects ; Adolescent ; Adult ; Aged ; Diabetes Mellitus, Type 2/blood ; Diabetes Mellitus, Type 2/epidemiology ; Dipeptides/adverse effects ; Dipeptidyl-Peptidase IV Inhibitors/adverse effects ; Double-Blind Method ; Drug Therapy, Combination ; Female ; Headache/chemically induced ; Headache/diagnosis ; Humans ; Hypoglycemic Agents/adverse effects ; Insulin/adverse effects ; Male ;Metformin /adverse effects ; Middle Aged ; Time Factors ; Treatment Outcome ; Urinary Tract Infections/chemically induced ; Urinary Tract Infections/diagnosis ; Young Adult
Czasopismo naukowe